Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Reference22 articles.
1. Benetti GP, Borzio M, Ramella G, et al., and GEL (Gruppo E patologico Lombardo). Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study.Intern Emerg Med 2006, 1: 113–8.
2. Zeuzem S, Schmidt JM, Lee JH, Ruster B, Roth WK. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.Hepatology 1996; 23: 366–71.
3. Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferonalpha therapy.Science 1998; 282: 103–7.
4. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden TJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa.Hepatology 1997; 26: 226–31.
5. Zeuzem S, Lee JH, Franke A, et al. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.Hepatology 1998; 27: 1149–56.